Elacestrant dihydrochloride
CAS 1349723-93-8
Em Estoque
Elacestrant dihydrochloride
Cat. No. ANT-ELC-001CAS 1349723-93-8Em Estoque
Dados Técnicos
Cat. No.ANT-ELC-001
CAS1349723-93-8
Fórmula Mol.C30H40Cl2N2O2
Peso Mol.531.56 g/mol
IUPAC(6R)-6-[2-[ethyl-[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol;dihydrochloride
SMILESOC1=CC=C2C[C@H](C3=CC=C(OC)C=C3N(CC)CC4=CC=C(CCNCC)C=C4)CCC2=C1.[H]Cl.[H]Cl
InChIInChI=1S/C30H38N2O2.2ClH/c1-4-31-17-16-22-6-8-23(9-7-22)21-32(5-2)30-20-28(34-3)14-15-29(30)26-11-10-25-19-27(33)13-12-24(25)18-26;;/h6-9,12-15,19-20,26,31,33H,4-5,10-11,16-18,21H2,1-3H3;2*1H/t26-;;/m1../s1
Chave InChIXGFHYCAZOCBCRQ-FBHGDYMESA-N
Pureza—
Descrição
Visão geral
Elacestrant dihydrochloride (sold as Orserdu) is an oral Selective Estrogen Receptor Degrader (SERD) approved to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. It is indicated for postmenopausal women and men whose disease progressed after endocrine therapy, acting by binding to and degrading estrogen receptors
A Anant Labs fabrica e fornece impurezas de Elacestrant dihydrochloride de alta qualidade para o mercado global. Nossas impurezas EP de Elacestrant dihydrochloride são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
(R)-6-(2-(Ethyl(4-(2-(ethylamino)ethyl)benzyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol dihydrochloride(6R)-6-{2-[ethyl({4-[2-(ethylamino)ethyl]phenyl}methyl)amino]-4-methoxyphenyl}-5,6,7,8-tetrahydronaphthalen-2-ol hydrochloride (1:2)(R)-6-[2-[Ethyl[4-(2-ethylaminoethyl)benzyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol DihydrochlorideElacestrant dihydrochloride1349723-93-8Elacestrant hydrochlorideRAD1901 dihydrochlorideRAD-1901 dihydrochloride8NZT0PR8AL2-Naphthalenol, 6-(2-(ethyl((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydro-, hydrochloride (1:2), (6R)-